176 related articles for article (PubMed ID: 6573941)
1. LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement.
Duque-Hammershaimb L; Wollner N; Miller DR
Cancer; 1983 Jul; 52(1):39-43. PubMed ID: 6573941
[TBL] [Abstract][Full Text] [Related]
2. Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
Vecchi V; Serra L; Pession A; Rosito P; Paolucci P; Burnelli R; Vivarelli F; Mancini AF; Paolucci G
Pediatr Hematol Oncol; 1986; 3(3):217-28. PubMed ID: 3153234
[TBL] [Abstract][Full Text] [Related]
3. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.
Patte C; Philip T; Rodary C; Bernard A; Zucker JM; Bernard JL; Robert A; Rialland X; Benz-Lemoine E; Demeocq F
J Clin Oncol; 1986 Aug; 4(8):1219-26. PubMed ID: 3525767
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
[TBL] [Abstract][Full Text] [Related]
5. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
6. Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Hvizdala EV; Berard C; Callihan T; Falletta J; Sabio H; Shuster JJ; Sullivan M; Wharam MD
J Clin Oncol; 1988 Jan; 6(1):26-33. PubMed ID: 3275750
[TBL] [Abstract][Full Text] [Related]
7. The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group.
Jenkin RD; Anderson JR; Chilcote RR; Coccia PF; Exelby PR; Kersey JH; Kushner JH; Meadows AT; Siegel SE; Sposto R
J Clin Oncol; 1984 Feb; 2(2):88-97. PubMed ID: 6366148
[TBL] [Abstract][Full Text] [Related]
8. Primary nasal-paranasal oropharyngeal lymphoma in the pediatric age group.
Wollner N; Mandell L; Filippa D; Exelby P; McGowan N; Lieberman P
Cancer; 1990 Mar; 65(6):1438-44. PubMed ID: 2306688
[TBL] [Abstract][Full Text] [Related]
9. [Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
Prats Viñas J; Gallego Melcón S; Pérez Payarols J; Macía Martí J; Sánchez de Toledo J
An Esp Pediatr; 1987 Jan; 26(1):15-21. PubMed ID: 3826937
[TBL] [Abstract][Full Text] [Related]
10. Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
Pullen DJ; Sullivan MP; Falletta JM; Boyett JM; Humphrey GB; Starling KA; Land VJ; Dyment PG; Vats T; Duncan MH
Blood; 1982 Nov; 60(5):1159-68. PubMed ID: 6982085
[TBL] [Abstract][Full Text] [Related]
11. Primary peripheral nodal lymphoma in children.
Wollner N; Exelby P; Lindsley KL; Lieberman P; Filippa D; Heller G
Cancer; 1993 Jun; 71(11):3670-9. PubMed ID: 8490916
[TBL] [Abstract][Full Text] [Related]
12. Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
de Andrea ML; de Camargo B; Correa Alves A; Machado JC; Franco EL
Cancer; 1988 Jul; 62(2):240-50. PubMed ID: 3383125
[TBL] [Abstract][Full Text] [Related]
13. [Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy?].
Pastore G; Cordero di Montezemolo L; Boschis MP; Ghibaudo P; Saracco P; Miniero R; Madon E; Forni M; Saitta M
Haematologica; 1985; 70(4):313-8. PubMed ID: 3935529
[No Abstract] [Full Text] [Related]
14. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
Patte C; Kalifa C; Flamant F; Hartmann O; Brugières L; Valteau-Couanet D; Bayle C; Caillaud JM; Lemerle J
Med Pediatr Oncol; 1992; 20(2):105-13. PubMed ID: 1734214
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Wollner N; Lieberman P; Exelby P; D'angio G; Burchenal J; Fang S; Murphy ML
Br J Cancer Suppl; 1975 Mar; 2():337-42. PubMed ID: 1058708
[TBL] [Abstract][Full Text] [Related]
16. Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
Waits TM; Greco FA; Greer JP; Johnson DH; Wolff SN; Stein RS; McMaster ML; Hainsworth JD
J Clin Oncol; 1993 May; 11(5):943-9. PubMed ID: 7683712
[TBL] [Abstract][Full Text] [Related]
17. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Steinherz PG; Gaynon PS; Breneman JC; Cherlow JM; Grossman NJ; Kersey JH; Johnstone HS; Sather HN; Trigg ME; Uckun FM; Bleyer WA
Cancer; 1998 Feb; 82(3):600-12. PubMed ID: 9452280
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma in children; diffuse lymphoblastic histology; diffuse non-lymphoblastic histology; LSA2-L2 experience.
Wollner N
An Esp Pediatr; 1988 Oct; 29 Suppl 34():122-6. PubMed ID: 3214018
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma in children.
Wollner N; Burchenal JH; Lieberman PH; Exelby PR; D'Angio GJ; Murphy ML
Med Pediatr Oncol; 1975; 1(3):235-63. PubMed ID: 1232532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
